Oligomerization of HEXIM1 via 7SK snRNA and coiled-coil region directs the inhibition of P-TEFb

Nucleic Acids Research

Volumn 33, Issue 22, 2005, Pages 7000-7010

  Blazek, Dalibor ^a   Barboric, Matjaz ^a   Kohoutek, Jiri ^a   Oven, Irena ^a,b   Peterlin, B Matija ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; RIBONUCLEASE; SMALL NUCLEAR RNA; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE MUTATION; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MUTAGENESIS; OLIGOMERIZATION; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; RNA BINDING;

AMINO ACID SEQUENCE; BINDING SITES; EVOLUTION, MOLECULAR; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RNA, SMALL NUCLEAR; RNA-BINDING PROTEINS; TRANSCRIPTION, GENETIC;

EUKARYOTA;

EID: 29244459405     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gki997     Document Type: Article

References (41)

1. Sims,R.J.,III, Belotserkovskaya,R. and Reinberg,D. (2004) Elongation by RNA polymerase II: The short and long of it. Genes Dev., 18, 2437-2468.
2. Barboric,M. and Peterlin,B.M. (2005) A new paradigm in eukaryotic biology: HIV Tat and the control of transcriptional elongation. PLoS Biol., 3, e76.
3. Price,D.H. (2000) P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol., 20, 2629-2634.
4. Shim,E.Y., Walker,A.K., Shi,Y. and Blackwell,T.K. (2002) CDK-9/cyclin T (P-TEFb) is required in two postinitiation pathways for transcription in the C.elegans embryo. Genes Dev., 16, 2135-2146.
5. Chao,S.H. and Price,D.H. (2001) Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo. J. Biol. Chem., 276, 31793-31799.
6. Garriga,J. and Grana,X. (2004) Cellular control of gene expression by T-type cyclin/CDK9 complexes. Gene, 337, 15-23.
7. Byers,S.A., Price,J.P., Cooper,J.J., Li,Q. and Price,D.H. (2005)HEXIM2, a HEXIM1 related protein, regulates P-TEFb through association with 7SK. J. Biol. Chem., 280, 16360-16367.
8. Michels,A.A., Fraldi,A., Li,Q., Adamson,T.E., Bonnet,F., Nguyen,V.T., Sedore,S.C., Price,J.P., Price,D.H., Lania,L. and Bensaude,O. (2004) Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/ cyclin T) inhibitor. EMBO J., 23, 2608-2619.
9. Michels,A.A., Nguyen,V.T., Fraldi,A., Labas,V., Edwards,M., Bonnet,F., Lania,L. and Bensaude,O. (2003) MAQ1 and 7SK RNA interact with CDK9/ cyclin T complexes in a transcription-dependent manner. Mol. Cell. Biol., 23, 4859-4869.
10. Nguyen,V.T., Kiss,T., Michels,A.A. and Bensaude,O. (2001) 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature, 414, 322-325.
11. Yang,Z., Zhu,Q., Luo,K. and Zhou,Q. (2001)The7SKsmall nuclearRNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature, 414, 317-322.
12. Yik,J.H., Chen,R., Pezda,A.C. and Zhou,Q. (2005) Compensatory contributions of HEXIM1 and HEXIM2 in maintaining the balance of active and inactive P-TEFb complexes for control of transcription. J. Biol. Chem., 280, 16368-16376.
13. Yik,J.H., Chen,R., Nishimura,R., Jennings,J.L., Link,A.J. and Zhou,Q. (2003) Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA. Mol. Cell, 12, 971-982.
14. Kulkarni,P.A., Sano,M. and Schneider,M.D. (2004) Phosphorylation of RNA polymerase II in cardiac hypertrophy: Cell enlargement signals converge on cyclinT/Cdk9. Recent Prog. Horm. Res., 59, 125-139.
15. Sano,M., Abdellatif,M., Oh,H., Xie,M., Bagella,L., Giordano,A., Michael,L.H., DeMayo,F.J. and Schneider,M.D. (2002) Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy. Nature Med., 8, 1310-1317.
16. Schulte,A., Czudnochowski,N., Barboric,M., Schonichen,A., Blazek,D., Peterlin,B.M. and Geyer,M. (2005) Identification of a dimeric Cyclin T-binding domain in HEXIM1 and biochemical analysis of its binding competition with HIV-1 Tat. J. Biol. Chem., 280, 24968-24977.
17. Taube,R., Lin,X., Irwin,D., Fujinaga,K. and Peterlin,B.M. (2002) Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes. Mol. Cell. Biol., 22, 321-331.
18. Ouchida,R., Kusuhara,M., Shimizu,N., Hisada,T., Makino,Y., Morimoto,C., Handa,H., Ohsuzu,F. and Tanaka,H. (2003) Suppression of NF-kappaB-dependent gene expression by a hexamethylene bisacetamide-inducible protein HEXIM1 in human vascular smooth muscle cells. Genes Cells, 8, 95-107.
19. Barboric,M., Kohoutek,J., Price,J.P., Blazek,D., Price,D.H. and Peterlin,B.M. (2005) Interplay between 75K sn RNA and oppositely charged regions in HEXIMA direct the inhibition of P-TEFb. EMBOJ., doi: 10.1038/ sj.emboj.7600883.
20. Makarova,O., Kamberov,E. and Margolis,B. (2000) Generation of deletion and point mutations with one primer in a single cloning step. Biotechniques, 29, 970-972.
21. Bornberg-Bauer,E., Rivals,E. and Vingron,M. (1998) Computational approaches to identify leucine zippers. Nucleic Acids Res., 26, 2740-2746.
22. Ross,S.E., Radomska,H.S., Wu,B., Zhang,P., Winnay,J.N., Bajnok,L., Wright,W.S., Schaufele,F., Tenen,D.G. and MacDougald,O.A. (2004) Phosphorylation of C/EBPalpha inhibits granulopoiesis. Mol. Cell. Biol., 24, 675-686.
23. Vinson,C., Myakishev,M., Acharya,A., Mi,A.A., Moll,J.R. and Bonovich,M. (2002) Classification of human B-ZIP proteins based on dimerization properties. Mol. Cell. Biol., 22, 6321-6335.
24. Sorkina,T., Doolen,S., Galperin,E., Zahniser,N.R. and Sorkin,A. (2003) Oligomerization of dopamine transporters visualized in living cells by fluorescence resonance energy transfer microscopy. J. Biol. Chem., 278, 28274-28283.
25. van Kuppeveld,F.J.M., Melchers,W.J.G., Willems,P.H.G.M. and Gadella,T.W.J.,Jr (2002) Homomultimerization of the Coxsackievirus 2B protein in living cells visualized by fluorescence resonance energy transfer microscopy. J. Virol., 76, 9446-9456.
26. Zacharias,D.A., Violin,J.D., Newton,A.C. and Tsien,R.Y. (2002) Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science, 296, 913-916.
27. Yik,J.H.N., Chen,R.C., Pezda,A.C., Samford,C.S. and Zhou,Q. (2004) A human immunodeficiency virus type 1 tat-like arginine-rich RNA-'binding domain is essential for HEXIM1 to inhibit RNA polymerase II transcription through 7SKsnRNA-mediated inactivation of P-TEFb. Mol. Cell. Biol., 24, 5094-5105.
28. Burkhard,P., Stetefeld,J. and Strelkov,S.V. (2001) Coiled coils: A highly versatile protein folding motif. Trends Cell Biol., 11, 82-88.
29. Klemm,J.D., Schreiber,S.L. and Crabtree,G.R. (1998) Dimerization as a regulatory mechanism in signal transduction. Annu. Rev. Immunol., 16, 569-592.
30. Wei,P., Garber,M.E., Fang,S.-M., Fischer,W.H. and Jones,K.A. (1998) A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop specific binding to TAR RNA. Cell, 92, 451-462.
31. Taube,R., Fujinaga,K., Irwin,D., Wimmer,J., Geyer,M. and Peterlin,B.M. (2000) Interactions between equine cyclin T1, Tat and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1. J. Virol., 74, 892-898.
32. Horn,W.T., Convery,M.A., Stonehouse,N.J., Adams,C.J., Liljas,L., Phillips,S.E.V. and Stockley,P.G. (2004) The crystal structure of a high affinity RNA stem-loop complexes with the bacteriophage MS2 capsid: Further challenges in the modeling of ligand-RNA interactions. RNA, 10, 1776-1782.
33. Peabody,D.S. (1997) Role of the coat protein-RNA interaction the life cycle of bacteriophage MS2. Mol. Gen. Genet., 254, 358-364.
34. Dulac,C., Michels,A.A., Fraldi,A., Bonnet,F., Nguyen,V.T., Napolitano,G., Lania,L. and Bensaude,O. (2005) Transcription-dependent association of multiple P-TEFb units to HEXIM multimer. J. Biol. Chem., 280, 30619-30629.
35. Li,Q., Price,J.P., Byers,S.A., Cheng,D., Peng,J. and Price,D.H. (2005) Analysis of the large inactive P-TEFb complex indicates that it contains one 7SK molecule, a dimer of HEXIM1 or HEXIM2, and two P-TEFb molecules containing Cdk9 phosphorylated at threonine 186. J. Biol. Chem., 280, 28819-28826.
36. Huang,F., Wagner,M. and Siddiqui,M.A. (2004) Ablation of the CLP-1gene leads to down-regulation of the HAND1 gene and abnormality of the left ventricle of the heart and fetal death. Mech. Dev., 121, 559-572.
37. Kusuhara,M., Nagasaki,K., Kimura,K., Maass,N., Manabe,T., Ishikawa,S., Aikawa,M., Miyazaki,K. and Yamaguchi,K. (1999) Cloning of hexamethylene-bis-acetamide-inducible transcript, HEXIM1, in human vascular smooth muscle cells. Biomed. Res., 20, 273-279.
38. Shan,B., Zhou,Y., Chin,D., Morris,C.A., Morris,G.F. and Lasky,J.A. (2005) Cyclin-dependent kinase 9 is required for tumor necrosis factor-alpha-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells. J. Biol. Chem., 280, 1103-1111.
39. Stone,B., Schummer,M., Paley,P.J., Thompson,L., Stewart,J., Ford,M., Crawford,M., Urban,N., O'Briant,K. and Nelson,B.H. (2003) Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q. Int. J. Cancer, 104, 73-84.
40. Wittmann,B.M., Fujinaga,K., Deng,H., Ogba,N. and Montano,M.M. (2005) The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1. Oncogene, 36, 5576-5588.
41. Wittmann,B.M., Wang,N. and Montano,M.M. (2003) Identification of a novel inhibitor of breast cell growth that is down-regulated by estrogens and decreased in breast tumors. Cancer Res., 63, 5151-5158.